Responses
Supplement
Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies
Compose a Response to This Article
Other responses
No responses have been published for this article.